Exogenous Insulin Products

All criteria may be applied retrospectively and each set identifies prospective application is indicated with an asterisk [*]. The information contained is for the convenience of the public. The Texas Health and Human Services Commission is not responsible for any errors in transmission or any errors or omissions in the document.

  • Revision history
    • Oct. 22, 2021; Sept. 2019.
  • Initially developed
    • June 2017